Results 241 to 250 of about 2,179,427 (282)
Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury? [PDF]
HepatologyGuo Q, Wang J, Wang G, Wang X.
europepmc +1 more source
Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis. [PDF]
PLoS OneOlson JC, Subramanian RM.
europepmc +1 more source
Erratum: Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial: Erratum. [PDF]
Crit Care Exploreuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hepatology, 2021
This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD).
S. Biggins +7 more
semanticscholar +1 more source
This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD).
S. Biggins +7 more
semanticscholar +1 more source
Expert Opinion on Pharmacotherapy, 2011
Hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Two different types of HRS have been described. Type 1 HRS develops as a consequence of a severe reduction of effective circulating volume due to both an extreme splanchnic arterial vasodilatation and a reduction of cardiac output.
ANGELI, PAOLO +3 more
openaire +5 more sources
Hepatorenal syndrome (HRS) is a functional renal failure that often occurs in patients with cirrhosis and ascites. Two different types of HRS have been described. Type 1 HRS develops as a consequence of a severe reduction of effective circulating volume due to both an extreme splanchnic arterial vasodilatation and a reduction of cardiac output.
ANGELI, PAOLO +3 more
openaire +5 more sources
Critical Care Medicine, 2022
OBJECTIVE: Hepatorenal syndrome (HRS) is associated with high rates of morbidity and mortality. Evidence examining commonly used drug treatments remains uncertain.
T. Pitre +9 more
semanticscholar +1 more source
OBJECTIVE: Hepatorenal syndrome (HRS) is associated with high rates of morbidity and mortality. Evidence examining commonly used drug treatments remains uncertain.
T. Pitre +9 more
semanticscholar +1 more source
Alimentary Pharmacology and Therapeutics, 2022
Hepatorenal syndrome (HRS) contributes to significant morbidity and mortality in hospitalised patients with cirrhosis.
A. Singal +4 more
semanticscholar +1 more source
Hepatorenal syndrome (HRS) contributes to significant morbidity and mortality in hospitalised patients with cirrhosis.
A. Singal +4 more
semanticscholar +1 more source